1. Shi, Jia'ning, Song, Shupeng, Li, Shuangxing, Lan, Yinghua, Li, Yongguo. 2021. TNF-α/NF-κB signaling epigenetically represses PSD4 transcription to promote alcohol-related hepatocellular carcinoma progression. In Cancer medicine, 10, 3346-3357. doi:10.1002/cam4.3832. https://pubmed.ncbi.nlm.nih.gov/33932127/
2. Zhang, Xiaochao, Hu, Yabing, Pan, Yonglong, Zhang, Zhanguo, Zhang, Bixiang. 2022. DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6. In Oncogene, 41, 1821-1834. doi:10.1038/s41388-022-02212-1. https://pubmed.ncbi.nlm.nih.gov/35140331/
3. Mancina, Rosellina M, Sasidharan, Kavitha, Lindblom, Anna, Lindén, Daniel, Romeo, Stefano. 2022. PSD3 downregulation confers protection against fatty liver disease. In Nature metabolism, 4, 60-75. doi:10.1038/s42255-021-00518-0. https://pubmed.ncbi.nlm.nih.gov/35102341/
4. Zhang, Yi, Li, Feilei, Chen, Jun. 2019. MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28. In Oncology reports, 41, 2511-2517. doi:10.3892/or.2019.6996. https://pubmed.ncbi.nlm.nih.gov/30720110/
5. Qiu, Peng-Cheng, Lu, Yun-Yang, Zhang, Shan, Tang, Hai-Feng, Cheng, Guang. 2020. Reduction of SCUBE3 by a new marine-derived asterosaponin leads to arrest of glioma cells in G1/S. In Oncogenesis, 9, 71. doi:10.1038/s41389-020-00252-4. https://pubmed.ncbi.nlm.nih.gov/32764572/